tiprankstipranks
Trending News
More News >
Bicycle Therapeutics (BCYC)
:BCYC
US Market

Bicycle Therapeutics (BCYC) Income Statement

Compare
370 Followers

Bicycle Therapeutics Income Statement

Last quarter (Q4 2024), Bicycle Therapeutics's total revenue was $3.71M, a decrease of -30.44% from the same quarter last year. In Q4, Bicycle Therapeutics's net income was $-51.85M. See Bicycle Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 35.27M$ 26.98M$ 14.46M$ 11.70M$ 10.39M
Gross Profit
$ 35.27M$ 20.51M$ 10.78M$ -33.18M$ -22.76M
Operating Expenses
$ 245.15M$ 216.92M$ 131.12M$ 77.31M$ 62.35M
Depreciation and Amortization
$ 7.17M$ 6.55M$ 3.69M$ 1.41M$ 1.29M
EBITDA
$ -164.89M$ -183.40M$ -112.96M$ -64.08M$ -50.39M
Operating Income
$ -209.87M$ -189.95M$ -116.65M$ -65.62M$ -51.96M
Other Income/Expenses
$ 36.08M$ 10.74M$ 2.41M$ -2.86M$ 226.00K
Pretax Income
$ -173.80M$ -179.21M$ -114.24M$ -68.48M$ -51.73M
Net Income
$ -169.03M$ -180.66M$ -112.72M$ -66.82M$ -51.01M
Per Share Metrics
Basic EPS
$ -0.29$ -5.08$ -3.80$ -2.67$ -2.66
Diluted EPS
$ -0.29$ -5.08$ -3.80$ -2.67$ -2.66
Weighted Average Shares Outstanding
582.08M 35.59M 29.66M 25.06M 19.15M
Weighted Average Shares Outstanding (Diluted)
582.08M 35.59M 29.66M 25.06M 19.15M
Currency in USD

Bicycle Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis